Parkinson’s disease therapy market

Nov 18, 2024

Parkinson’s disease is the second most common neurodegenerative disorder after Alzheimer’s disease. It affects about 10 million people worldwide. The average age of onset for Parkinson’s disease is around 60; however, approximately 10-15% of patients experience early-onset PD before the age of 50. In 2023, there...

Dec 31, 2021

Parkinson's disease is a neurodegenerative disorder that affects predominately dopamine-producing (“dopaminergic”) neurons in a specific area of the brain called substantia nigra. Parkinson's disease has four main symptoms such as tremor (trembling) in hands, arms, legs, jaw, or head, stiffness of the limbs and tru...

Nov 11, 2019

Parkinson's disease prevalence is rising. According to a survey conducted by Parkinson.org, around one million people in the US will be living with Parkinson’s disease by the end of 2020. The number is shockingly high as the prevalence of multiple sclerosis combined with muscular dystrophy and Lou Gehrig’s dise...